IMVT
Immunovant, Inc. · Healthcare
Chief Technology Officer Jay S Stout sold $122K of Immunovant, Inc.
Sold$122,117
$32.06Price
3,809Shares
−2%Stake
What IMVT did after the filing
- The stock from Mon, Oct 12 open, $30.17
- −5.8%
- S&P 500, same days
- −2.4%
9 of 30 trading days so far, to the Oct 23 close.
Traded Wed, Oct 7. Filed Fri, Oct 9, 5:05 PM ET, after the close. Returns use the Oct 12 open and the Oct 23 close. Not investment advice.